Pneumonia

Infectious Disease·MeSH: Pneumonia

48 drugs in development·34 companies·14 clinical trials

Drug Pipeline by Phase

Approved(28)

Drug	Company
amoxicillin	Miromatrix Medical Inc. (MIRO)
azithromycin	SUNSET ISLAND GROUP (SUN)
baxdela	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
Capvaxive	Merck & Co., Inc. (MRK)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
cefepime	Seagen Inc. (SGEN)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
clarithromycin	SUNSET ISLAND GROUP (SUN)
Clarithromycin Granules and Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
Double - Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
Double-Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
emblaveo	AbbVie Inc. (ABBV)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
minocycline	NEXUS BIOPHARMA INC (NEXS)
orlynvah	Iterum Therapeutics plc (ITRM)
Roxithromycin Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
XACDURO	Innoviva, Inc. (INVA)
XACDURO®	Innoviva, Inc. (INVA)
zerbaxa	Curative Biotechnology Inc (CUBT)
zevtera	Innoviva, Inc. (INVA)
ZEVTERA®	Innoviva, Inc. (INVA)

Phase 3(6)

Drug	Company
agent-797	ImmunityBio, Inc. (IBRX)
AR-301	Aridis Pharmaceuticals, Inc. (ARDS)
AR-320	Aridis Pharmaceuticals, Inc. (ARDS)
ceftazidime-avibactam	NYMOX PHARMACEUTICAL CORP (NYMXF)
meropenem	NYMOX PHARMACEUTICAL CORP (NYMXF)
sul-dur	Entasis Therapeutics Holdings Inc. (ETTX)

Phase 2(3)

Drug	Company
Auxora	CalciMedica, Inc. (CALC)
cal02	EAGLE PHARMACEUTICALS, INC. (EGRX)
cm4620-ie	CalciMedica, Inc. (CALC)

Phase 1(3)

Drug	Company
agent-797	MiNK Therapeutics, Inc. (INKT)
nogapendekin alfa inbakicept	ImmunityBio, Inc. (IBRX)
tp-271	TETRAPHASE PHARMACEUTICALS INC (TTPH)

Preclinical(3)

Drug	Company
SG-001	ADMA BIOLOGICS, INC. (ADMA)
tp-271	LA JOLLA PHARMACEUTICAL CO (LJPC)
vibativ	SCICLONE PHARMACEUTICALS INC (SCLN)

Unknown(2)

Drug	Company
200 ppm nitric	GH Research PLC (GHRS)
CHS430 (VOC POCT)	Ainos Inc. (AIMD)

Phase 1/Phase 2(1)

Drug	Company
AP-PA03	Armata Pharmaceuticals, Inc. (ARMP)

Phase 4(2)

Drug	Company
Acetyl cysteine	ENANTA PHARMACEUTICALS INC (ENTA)
sham treatment	GH Research PLC (GHRS)

BioSniper tracks 48 drugs in development for Pneumonia across 34 companies.

There are 14 clinical trials targeting Pneumonia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.